ZALEPLON (zaleplon) by Hikma is clinical pharmacology pharmacodynamics and mechanism of action while zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (gaba-bz) receptor complex. Approved for gamma-aminobutyric acid a receptor agonist [epc]. First approved in 2008.
Drug data last refreshed 21h ago
CLINICAL PHARMACOLOGY Pharmacodynamics and Mechanism of Action While zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor…
Worked on ZALEPLON at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Zaleplon 10 mg Capsules Under Non-Fasting Conditions
Zaleplon 10mg Capsules Under Fasting Conditions